The aberrant expression of CTHRC1 has been documented in various cancers, including breast cancer, stomach adenocarcinoma, non-small cell lung cancer, and colon adenocarcinoma [19–22]. This evidence concerns the gene CTHRC1 and non-small cell lung carcinoma.